Literature DB >> 17554121

Local therapy and survival in breast cancer.

Rinaa S Punglia1, Monica Morrow, Eric P Winer, Jay R Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17554121     DOI： 10.1056/NEJMra065241

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  71 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Robotic D2 surgery for gastric cancer.

Authors:  H Demetetriades; G N Marakis; D Ziogas; I Kanellos
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

3.  Advanced gastric cancer: is laparoscopic gastrectomy safe?

Authors:  T Liakakos; E P Misiakos; A Macheras
Journal:  Surg Endosc       Date:  2009-03-19       Impact factor: 4.584

4.  Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.

Authors:  Clifton D Fuller; Samuel J Wang; Mehee Choi; Brian G Czito; John Cornell; Tania M Welzel; Katherine A McGlynn; Join Y Luh; Charles R Thomas
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

Review 5.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

6.  Impact of margin assessment method on positive margin rate and total volume excised.

Authors:  Tracy-Ann Moo; Lydia Choi; Candice Culpepper; Cristina Olcese; Alexandra Heerdt; Lisa Sclafani; Tari A King; Anne S Reiner; Sujata Patil; Edi Brogi; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

7.  Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Authors:  Yvonne L Chao; Christopher R Shepard; Alan Wells
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

8.  On the way to specifically targeting minimal residual disease?

Authors:  Gerhard Gebauer
Journal:  Breast Cancer Res       Date:  2008-10-07       Impact factor: 6.466

Review 9.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466

Review 10.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.